Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.

In the current study we attempted to evaluate the suitability of T7 Select 10-3b and lambdaKM8 phage display systems for the identification of antigens eliciting B cell responses in cancer patients and the production of phage-displayed antigen microarrays that could be exploited for the monitoring of autoantibody profiles. Members of 15 tumour-associated antigen (TAA) families were cloned into both phage display vectors and the TAA mini-libraries were immunoscreened with 22 melanoma patients' sera resulting in the detection of reactivity against members of 5 antigen families in both systems, yet with variable sensitivity. T7 phage display system showed greater sensitivity for the detection of antibodies against members of CTAG, MAGEA and GAGE families, both systems showed equal performance in detecting the reactivity against MAGEC and SSX2 while only lambdaKM8 allowed the detection of anti-CTAGE5 antibodies. The biological properties of both phages turned out to be equally suitable for the production of antigen microarrays however in line with the plaque assay the sensitivity for the detection of various autoantibodies differed between the vectors. However, presumably due to the higher variability of the background signals in the microarray assay, it turned out to have comparable, in some cases even slightly lower sensitivity than the plaque assay. Next, we explored the repertoire of antigens that could be identified by screening T7 phage-displayed testis cDNA library with sera from melanoma patients. From the 243 antigens identified, only 24 represented known genes translated in their natural reading frame and included known TAAs like Annexin XI-A and a novel potential CT antigen SPAG8. Another 12 were uncharacterised genes but the remaining clones contained DNA fragments in non-natural reading frames that most likely represent mimotopes, nevertheless, they may turn out to be valid biomarkers.

[1]  A. Wlodawer,et al.  Novel fold and capsid-binding properties of the λ-phage display platform protein gpD , 2000, Nature Structural Biology.

[2]  Arnold J Stromberg,et al.  Using protein microarray as a diagnostic assay for non-small cell lung cancer. , 2005, American journal of respiratory and critical care medicine.

[3]  J. Blay,et al.  Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome , 2006, British Journal of Cancer.

[4]  Franco Felici,et al.  Identification of tumor‐associated antigens by screening phage‐displayed human cDNA libraries with sera from tumor patients , 2003, International journal of cancer.

[5]  E. Smeland,et al.  Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display , 2004, Cancer Immunology, Immunotherapy.

[6]  M. Griffioen,et al.  CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame , 2003, The Journal of Immunology.

[7]  M. Pfreundschuh,et al.  Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G Cesareni,et al.  Selection of ligands by panning of domain libraries displayed on phage lambda reveals new potential partners of synaptojanin 1. , 2001, Journal of molecular biology.

[9]  Gerard Tromp,et al.  Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. , 2006, Cancer research.

[10]  F. Felici,et al.  Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage , 2004, BMC Cancer.

[11]  Chen Xu,et al.  Inhibition of mouse acrosome reaction and sperm-zona pellucida binding by anti-human sperm membrane protein 1 antibody. , 2007, Asian journal of andrology.

[12]  M. Sioud,et al.  Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour. , 2001, International journal of oncology.

[13]  H. Moch,et al.  Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients , 2006, Cancer Immunology, Immunotherapy.

[14]  P. VandeVord,et al.  Antinuclear antibodies as potential markers of lung cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  J. Arends,et al.  Phage display of cDNA repertoires: the pVI display system and its applications for the selection of immunogenic ligands. , 1999, Journal of immunological methods.

[16]  T. Soussi,et al.  p53 Antibodies in the sera of patients with various types of cancer: a review. , 2000, Cancer research.

[17]  A. Stromberg,et al.  Identification of circulating antibodies to tumor‐associated proteins for combined use as markers of non‐small cell lung cancer , 2004, Proteomics.

[18]  S. Peñuelas,et al.  Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells , 2006, International Journal of Gynecologic Cancer.

[19]  Ruurd van der Zee,et al.  Prediction of sequential antigenic regions in proteins , 1985, FEBS letters.

[20]  Lee Makowski,et al.  T7 lytic phage‐displayed peptide libraries exhibit less sequence bias than M13 filamentous phage‐displayed peptide libraries , 2006, Proteomics.

[21]  U. Fischer,et al.  Autoantibodies against GLEA2 and PHF3 in glioblastoma: Tumor‐associated autoantibodies correlated with prolonged survival , 2005, International journal of cancer.

[22]  Dirk Schadendorf,et al.  cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. , 2003, The Journal of investigative dermatology.

[23]  J. Arends,et al.  A Panel of Candidate Tumor Antigens in Colorectal Cancer Revealed by the Serological Selection of a Phage Displayed cDNA Expression Library1 , 2002, The Journal of Immunology.

[24]  Lloyd J. Old,et al.  A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.

[25]  A. Frigessi,et al.  Analysis of the humoral immune response to immunoselected phage‐displayed peptides by a microarray‐based method , 2004, Proteomics.

[26]  K. Hemminki,et al.  p53 autoantibodies predict subsequent development of cancer , 2005, International journal of cancer.

[27]  W. Willats,et al.  Phage display: practicalities and prospects , 2002, Plant Molecular Biology.

[28]  G. Rosenberg,et al.  T7 Select Phage Display System: a powerful new protein display system based on bacteriophage T7 , 1998 .

[29]  M. Sioud,et al.  Profiling the immune response in patients with breast cancer by phage‐displayed cDNA libraries , 2001, European journal of immunology.

[30]  Reinhard Dummer,et al.  Proteomic Scan for Tyrosinase Peptide Antigenic Pattern in Vitiligo and Melanoma: Role of Sequence Similarity and HLA-DR1 Affinity1 , 2005, The Journal of Immunology.

[31]  Debashis Ghosh,et al.  Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.